|
PCNT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.3391999997836E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.55589999667671E-08 |
| Normal-vs-Stage2 |
3.261800E-03 |
| Normal-vs-Stage3 |
6.581600E-04 |
| Normal-vs-Stage4 |
2.99280000004565E-06 |
| Stage1-vs-Stage2 |
6.280800E-01 |
| Stage1-vs-Stage3 |
3.270000E-01 |
| Stage1-vs-Stage4 |
2.260600E-01 |
| Stage2-vs-Stage3 |
7.932400E-01 |
| Stage2-vs-Stage4 |
2.394800E-01 |
| Stage3-vs-Stage4 |
1.167240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.13099999657862E-08 |
| Normal-vs-AfricanAmerican |
2.29169999999002E-05 |
| Normal-vs-Asian |
8.518000E-03 |
| Caucasian-vs-AfricanAmerican |
5.721400E-01 |
| Caucasian-vs-Asian |
8.357400E-01 |
| AfricanAmerican-vs-Asian |
9.962400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32719962692352E-10 |
| Normal-vs-Female |
1.863970E-03 |
| Male-vs-Female |
1.762980E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.93129999995312E-06 |
| Normal-vs-Extreme_Weight |
2.07300000498734E-08 |
| Normal-vs-Obese |
7.575400E-04 |
| Normal-vs-Extreme_Obese |
3.39839999996538E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.025800E-01 |
| Normal_Weight-vs-Obese |
1.834410E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.812600E-01 |
| Extreme_Weight-vs-Obese |
1.499560E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.570600E-01 |
| Obese-vs-Extreme_Obese |
7.596000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.222490E-02 |
| Normal-vs-Age(41-60Yrs) |
3.88080000000013E-05 |
| Normal-vs-Age(61-80Yrs) |
1.53429999816268E-08 |
| Normal-vs-Age(81-100Yrs) |
6.22369999980776E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.750200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.244100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.826430E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.090400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.701600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.649600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.58659999985822E-07 |
| Normal-VS-Type2 PRCC |
6.71410038677323E-10 |
| Normal-VS-KIRP CIMP |
1.152180E-01 |
| Normal-VS-Unclassified PRCC |
9.61210000000046E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.515800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.204830E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.528400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.029790E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.208400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.827190E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.3377999819042E-09 |
| Normal-vs-N1 |
8.424400E-04 |
| Normal-vs-N2 |
3.798300E-03 |
| N0-vs-N1 |
7.870100E-02 |
| N0-vs-N2 |
5.613400E-01 |
| N1-vs-N2 |
2.451600E-01 |
|
|
